Literature DB >> 10049298

Genetic evidence that InhA of Mycobacterium smegmatis is a target for triclosan.

L M McMurry1, P F McDermott, S B Levy.   

Abstract

Three Mycobacterium smegmatis mutants selected for resistance to triclosan each had a different mutation in InhA, an enoyl reductase involved in fatty acid synthesis. Two expressed some isoniazid resistance. A mutation originally selected on isoniazid also mediated triclosan resistance, as did the wild-type inhA gene on a multicopy plasmid. Replacement of the mutant chromosomal inhA genes with wild-type inhA eliminated resistance. These results suggest that M. smegmatis InhA, like its Escherichia coli homolog FabI, is a target for triclosan.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10049298      PMCID: PMC89191     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Triclosan targets lipid synthesis.

Authors:  L M McMurry; M Oethinger; S B Levy
Journal:  Nature       Date:  1998-08-06       Impact factor: 49.962

2.  NADH dehydrogenase defects confer isoniazid resistance and conditional lethality in Mycobacterium smegmatis.

Authors:  L Miesel; T R Weisbrod; J A Marcinkeviciene; R Bittman; W R Jacobs
Journal:  J Bacteriol       Date:  1998-05       Impact factor: 3.490

3.  Antimicrobial spectrum of Triclosan, a broad-spectrum antimicrobial agent for topical application.

Authors:  W A Vischer; J Regös
Journal:  Zentralbl Bakteriol Orig A       Date:  1974-03

4.  Triclosan: applications and safety.

Authors:  H N Bhargava; P A Leonard
Journal:  Am J Infect Control       Date:  1996-06       Impact factor: 2.918

5.  Intrinsic resistance to inhibitors of fatty acid biosynthesis in Pseudomonas aeruginosa is due to efflux: application of a novel technique for generation of unmarked chromosomal mutations for the study of efflux systems.

Authors:  H P Schweizer
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

6.  A mechanism of drug action revealed by structural studies of enoyl reductase.

Authors:  C Baldock; J B Rafferty; S E Sedelnikova; P J Baker; A R Stuitje; A R Slabas; T R Hawkes; D W Rice
Journal:  Science       Date:  1996-12-20       Impact factor: 47.728

7.  Enzymatic characterization of the target for isoniazid in Mycobacterium tuberculosis.

Authors:  A Quémard; J C Sacchettini; A Dessen; C Vilcheze; R Bittman; W R Jacobs; J S Blanchard
Journal:  Biochemistry       Date:  1995-07-04       Impact factor: 3.162

8.  Superinfection immunity of mycobacteriophage L5: applications for genetic transformation of mycobacteria.

Authors:  M K Donnelly-Wu; W R Jacobs; G F Hatfull
Journal:  Mol Microbiol       Date:  1993-02       Impact factor: 3.501

9.  inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis.

Authors:  A Banerjee; E Dubnau; A Quemard; V Balasubramanian; K S Um; T Wilson; D Collins; G de Lisle; W R Jacobs
Journal:  Science       Date:  1994-01-14       Impact factor: 47.728

10.  Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis.

Authors:  A Dessen; A Quémard; J S Blanchard; W R Jacobs; J C Sacchettini
Journal:  Science       Date:  1995-03-17       Impact factor: 47.728

View more
  48 in total

Review 1.  Potential impact of increased use of biocides in consumer products on prevalence of antibiotic resistance.

Authors:  Peter Gilbert; Andrew J McBain
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

2.  Molecular basis for triclosan activity involves a flipping loop in the active site.

Authors:  X Qiu; C A Janson; R I Court; M G Smyth; D J Payne; S S Abdel-Meguid
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

Review 3.  Targeting InhA, the FASII enoyl-ACP reductase: SAR studies on novel inhibitor scaffolds.

Authors:  Pan Pan; Peter J Tonge
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

Review 4.  The reductase steps of the type II fatty acid synthase as antimicrobial targets.

Authors:  Yong-Mei Zhang; Ying-Jie Lu; Charles O Rock
Journal:  Lipids       Date:  2004-11       Impact factor: 1.880

5.  Chronic arsenic exposure and microbial drug resistance.

Authors:  Malcolm J McConville; Stuart A Ralph
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-13       Impact factor: 11.205

Review 6.  Current and Emerging Topical Antibacterials and Antiseptics: Agents, Action, and Resistance Patterns.

Authors:  Deborah A Williamson; Glen P Carter; Benjamin P Howden
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

Review 7.  Clinical implication of novel drug resistance-conferring mutations in resistant tuberculosis.

Authors:  N P Mnyambwa; D-J Kim; E S Ngadaya; R Kazwala; P Petrucka; S G Mfinanga
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-06-07       Impact factor: 3.267

Review 8.  Epidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubs.

Authors:  Günter Kampf; Axel Kramer
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

9.  Exploring the chemical space of 1,2,3-triazolyl triclosan analogs for discovery of new antileishmanial chemotherapeutic agents.

Authors:  Julia Fernández de Luco; Alejandro I Recio-Balsells; Diego G Ghiano; Ana Bortolotti; Juán Manuel Belardinelli; Nina Liu; Pascal Hoffmann; Christian Lherbet; Peter J Tonge; Babu Tekwani; Héctor R Morbidoni; Guillermo R Labadie
Journal:  RSC Med Chem       Date:  2020-11-05

10.  Design and synthesis of aryl ether inhibitors of the Bacillus anthracis enoyl-ACP reductase.

Authors:  Suresh K Tipparaju; Debbie C Mulhearn; Gary M Klein; Yufeng Chen; Subhasish Tapadar; Molly H Bishop; Shuo Yang; Juan Chen; Mahmood Ghassemi; Bernard D Santarsiero; James L Cook; Mary Johlfs; Andrew D Mesecar; Michael E Johnson; Alan P Kozikowski
Journal:  ChemMedChem       Date:  2008-08       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.